SCHEMBL1016221

SCHEMBL1016221

CCN(C)C/C=C/C(=O)N1CCc2c(sc3ncnc(Nc4ccc5c(cnn5Cc5ccccn5)c4)c23)C1

nearest known ligand 0.55

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGFR P00533 19/20 0.55
ERBB2 P04626 2/20 0.48
KCNH2 Q12809 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1016223 1.00 EGFR (0.55) EGFRERBB2KCNH2
SCHEMBL1015547 0.94 EGFR (0.57) EGFRERBB2
SCHEMBL1015545 0.94 EGFR (0.57) EGFRERBB2
SCHEMBL1015944 0.94 EGFR (0.61) EGFRERBB2KCNH2
SCHEMBL1015945 0.94 EGFR (0.61) EGFRERBB2KCNH2
SCHEMBL1019309 0.92 EGFR (0.64) EGFRERBB2KCNH2
SCHEMBL1016626 0.92 EGFR (0.60) EGFRERBB2KCNH2
SCHEMBL1019308 0.92 EGFR (0.64) EGFRERBB2KCNH2
SCHEMBL1016625 0.92 EGFR (0.60) EGFRERBB2KCNH2
SCHEMBL13037042 0.92 EGFR (0.59) EGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2001890-B1 TETRAHYDROPYRIDOTHIENOPYRIMIDINE COMPOUNDS AND USE FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS BAYER SCHERING PHARMA AG (DE) 2011-01-12 EP disclosed
EP-2001890-B1 TETRAHYDROPYRIDOTHIENOPYRIMIDINE COMPOUNDS AND USE FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS BAYER SCHERING PHARMA AG (DE) 2011-01-12 EP disclosed